Biotech stocks are surging. How investors can play the new drug innovation boom

1 publisher first detected 1h ago 2% of 42 Business publishers

Headline as filed by CNBC Top News.

Compare coverage — 1 report

Every publisher that filed on this event, earliest first, with each one's headline, summary, times and how long after the first report they filed.
Publisher	Headline	Summary	Published	Detected	Delay	Source	Status
CNBC Top News	Biotech stocks are surging. How investors can play the new drug innovation boom	Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.	24 Oct, 13:10	24 Oct, 13:15	0m	cnbc.com	First

Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.

Reader comments

Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.

Nobody has commented on this story yet.

Related coverage

connected by shared subjects

Biotech stocks are surging. How investors can play the new drug innovation boom

Compare coverage — 1 report

Reader comments

Add a comment

Related coverage

AI fever ignites a boom in thematic ETFs as fund managers hunt for their next big hit

Buzzy insurtech Corgi is hiring experienced investment bankers. The catch? The pay is commission-only.

NYSE becomes latest exchange to extend options hours as appetite for around-the-clock trading grows

Boomers are buying into the promise of monthly income from options ETFs, but there's a tax catch

Cboe to expand options trading hours for major stocks and ETFs

Hundreds of new pro sports team ETFs lead world of retail investing to the edge of gambling